Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 5 of 44, showing 5 Applications out of 217 total, starting on record 21, ending on 25

# Protocol No Study Title Investigator(s) & Site(s) Application Status

21.

ECCT/19/06/01   EPI 003
    A prospective study to evaluate the safety, effectiveness and impact of the RTS,S/AS01E vaccine in young children in sub-Saharan Africa.   
Principal Investigator(s)
1. Walter Otieno
Site(s) in Kenya
1. Ahero clinical triasl unit (Kisumu county)
2. KEMI CDC (Siaya county)
 
Trial Status Stopped
Protocol Date 11-10-2017
View

22.

ECCT/19/07/01   IMPROVE-2
      chemoprevention with monthly IPTp with dihydroartemisinin-piperaquine for malaria in HIV-infected pregnant participants on daily cotrimoxazole in Kenya and Malawi: a multi-centre placebo-controlled trial(IMPROVE-2).    
Principal Investigator(s)
1. Hellen Cherono Barsosio
2. Simon Kariuki
Site(s) in Kenya
1. Ahero Sub-County Hospital (Kisumu county)
2. Rabuor Sub-County Hospital (Kisumu county)
3. Akala Sub-County Hospital (Siaya county)
 
Trial Status Recruiting
Protocol Date 17-05-2019
View

23.

ECCT/19/05/02   ETNA
    EVALUATION OF TECHNOLOGIES FOR NEONATES IN AFRICA   
Principal Investigator(s)
1. PROF WILLIAM MAINA MACHARIA
Site(s) in Kenya
1. AGA KHAN UNIVERSITY HOSPITAL (Nairobi City county)
2. PUMWANI MATERNITY HOSPITAL (Nairobi City county)
 
Trial Status Recruiting
Protocol Date 25-02-2019
View

24.

ECCT/19/08/02   LOxaF- N Trial
    LOW DOSE OXYTOCIN AS AN ADJUNCT TO FOLEY CATHETER FOR CERVICAL RIPENING IN NULLIPAROUS WOMEN AT MTRH, ELDORET, KENYA: A RANDOMISED CONTROLLED TRIAL.   
Principal Investigator(s)
1. Patrick Omondi Otieno
Site(s) in Kenya
The Riley Mother and Baby Hospital (RMBH) at Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya.
 
Trial Status Analysing
Protocol Date 26-09-2018
View

25.

ECCT/19/04/02   NADIA \"Nucleosides And Darunavir/Dolutegravir In Africa\"
    A randomised controlled trial of darunavir versus dolutegravir and tenofovir versus zidovudine in second-line antiretroviral therapy regimens for the public health approach in sub-Saharan Africa   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
Moi University Clinical Research Centre
 
Trial Status In follow-up
Protocol Date 14-11-2018
View